Tr1 cells for use in atherosclerosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 26, 2011
Issued Date -
N/A
app pub date -
Aug 11, 2004
filing date -
Aug 11, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a method of treating or preventing atherosclerosis comprising administering to a mammal in need of such a treatment a) an antigen which has been used to activate in vitro a Tri cell population originating from said mammal, and b) the TO cell population activated by said antigen, said TO cell population being obtained from a CD4+ T lymphocyte population of said mammal.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully